A. Goldfarb

Safety and efficacy of procainamide infusions.

W. Jusko, J. Lima, A. Goldfarb, 1979, The American journal of cardiology.

The Effect of Verapamil on the Nephrotoxic Potential of Gentamicin as Measured by Urinary Enzyme Excretion in Healthy Volunteers

Jerome J. Schentag, D. Kazierad, D. Nix, 1995, Journal of clinical pharmacology.

Nitroglycerin pharmacokinetics after intravenous infusion in normal subjects.

A. Yacobi, H. Fung, A. Goldfarb, 1981, Journal of pharmaceutical sciences.

Exceptional survival of a patient with large ventricular septal defect, bidirectional shunt, and severe pulmonary valve stenosis.

J. Izzo, A. Yahia, Abutaher M. Yahia, 2002, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

pH-dependent secretion of procainamide into saliva.

W. Jusko, J. Koup, A. Goldfarb, 1975, Journal of pharmaceutical sciences.

Pharmacokinetic Design of Digoxin Dosage Regimens in Relation to Renal Function

W. Jusko, S. Szefler, A. Goldfarb, 1974, Journal of clinical pharmacology.

Pharmacokinetic approach to intravenous procainamide therapy

W. Jusko, J. Lima, A. Goldfarb, 1978, European Journal of Clinical Pharmacology.

Clinical pharmacokinetics of procainamide infusions in relation to acetylator phenotype

William J. Tilstone, William J. Jusko, W. Jusko, 1979, Journal of Pharmacokinetics and Biopharmaceutics.

Enhanced Pirmenol Elimination by Rifampin

K. Stringer, A. Sedman, A. Goldfarb, 1988, Journal of clinical pharmacology.